Local moderate magnetically induced hyperthermia using an implant formed in situ in a mouse tumor model

International Journal of Hyperthermia

Volumn 25, Issue 3, 2009, Pages 229-239

  Renard, Pol Edern Le ^a   Buchegger, Franz ^b   Petri Fink, Alke ^c   Bosman, Frederik ^b   Rfenacht, Daniel ^d   Hofmann, Heinrich ^c   Doelker, Eric ^a   Jordan, Olivier ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c EPFL   (Switzerland)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Implant; Magnetic induced hyperthermia; Necrotizing colocarcinoma; Precipitating polymers; Subcutaneous xenograft; Superparamagnetic nanoparticles; Survival; Thermometry

Indexed keywords

SILICON DIOXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; IRON; MICROSPHERE; NANOPARTICLE; OXIDE; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER SURVIVAL; COLON CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; HISTOPATHOLOGY; HYPERTHERMIC THERAPY; IMPLANT; MAGNETIC FIELD; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRECIPITATION; SURVIVAL TIME; TEMPERATURE MEASUREMENT; THERMOMETRY; TUMOR NECROSIS; ANIMAL; CANCER TRANSPLANTATION; COLON TUMOR; FEASIBILITY STUDY; HUMAN; MAGNETISM; METHODOLOGY; NUDE MOUSE;

ANIMALS; APOPTOSIS; COLONIC NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; IMPLANTS, EXPERIMENTAL; IRON; MAGNETICS; MICE; MICE, NUDE; MICROSPHERES; NANOPARTICLES; NEOPLASM TRANSPLANTATION; OXIDES; SILICON DIOXIDE;

EID: 67949123331     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730802713557     Document Type: Article

References (46)

1. Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002;43:33-56.
2. Hand JW, Streffer C, van Beuningen D, Vaupel P, Kallinowski F, Molls M, Scherer E, Engelhardt R. Hyperthermia and the Therapy of Malignant Tumors. Berlin: Springer-Verlag; 1987.
3. Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia 2001;17:1-18.
4. Dewhirst MW, Viglianti BL, Lora-Michiels M, Hanson M, Hoopes PJ. Basic principles of thermal dosimetry and thermal thresholds for tissue damage form hyperthermia. Int J Hyperthermia 2003;19:267-294.
5. Sapozink MD, Corry PM, Kapp DS, Myerson RJ, Dewhirst MW, Emami B, Herman T, Prionas S, Ryan T, Samulski T, et al. RTOG Quality assurance guidelines for clinical trials using hyperthermia for deep-seated malignancy. Int J Radiat Oncol Biol Phys 1991;20:1109-1115.
6. Rosensweig RE. Heating magnetic fluid with alternating magnetic field. J Magn Magn Mater 2002;252:370-374.
7. Wang XM, Gu HC, Yang ZQ. The heating effect of magnetic fluids in an alternating magnetic field. J Magn Magn Mater 2005;293:334-340.
8. Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids - Physical evaluation of their potential for hyperthermia. Int J Hyperthermia 1993;9:51-68.
9. Jordan A, Scholz R, Wust P, Fahling H, Felix R. Magnetic fluid hyperthermia. In: Hafeli U, Schütt W, Teller J, and Zborowski M, editors. Scientific and Clinical Applications of Magnetic Carriers. New York: Plenum Press; 1997. pp 569-595.
10. Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, Waldofner N, Scholz R, Jordan A, Loening SA, Wust P. Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging, and threedimensional temperature distribution. Eur Urol 2006;52: 1653-1662.
11. Wust P, Gneveckow U, Johannsen M, Bohmer D, Henkel T, Kahmann F, Sehouli J, Felix R, Ricke J, Jordan A. Magnetic nanoparticles for interstitial thermotherapy-feasibility, tolerance and achieved temperatures. Int J Hyperthermia 2006; 22:673-685.
12. Johannsen M, Gneveckow U, Taymoorian K, Thiesen B, Waldofner N, Scholz R, Jung K, Jordan A, Wust P, Loening SA. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial. Int J Hyperthermia 2007;23:315-323.
13. Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, Feussner A, von Deimling A, Waldoefner N, Felix R, et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: Results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol 2007;81:53-60.
14. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: Current status and future prospects. FASEB J 2005; 19:311-330.
15. Chastellain M, Petri A, Gupta A, Rao KV, Hofmann H. Superparamagnetic silica-iron oxide nanocomposites for application in hyperthermia. Adv Eng Mater 2004;6:235-241.
16. Povlsen CO, Rygaard J. Heterotransplantation of human adenocarcinomas of colon and rectum to mouse mutant nude. A study of 9 consecutive transplantations. Acta Pathol Microbiol Scand A 1971;79:159-169.
17. Sun LQ, Vogel CA, Mirimanoff RO, Coucke P, Slosman DO, Mach JP, Buchegger F. Timing effects of combined radioimmunotherapy and radiotherapy on a human solid tumor in nude mice. Cancer Res 1997;57:1312-1319.
18. Sutherland R, Buchegger F, Schreyer M, Vacca A, Mach JP. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. Cancer Res 1987;47:1627-1633.
19. Budden R, Kuhl UG, Buschmann G. Studies on pharmacodynamic activity of several drug solvents. 1. Diethyleneglycolmonoethylether, N,N-Diethylacetamide, Dimethylsulfoxide. Arzneimittelforschung 1978;28: 1571-1579. (Pubitemid 9012186)
20. Mottu F, Laurent A, Rüfenacht DA, Doelker E. Organic solvents for pharmaceutical parenterals and embolic liquids. A review of toxicity data. PDA J Pharm Sci Technol 2000;54:456-469.
21. Mottu F, Stelling MJ, Rüfenacht DA, Doelker E. Comparative hemolytic activity of undiluted organic watermiscible solvents for intravenous and intra-arterial injection. PDA J Pharm Sci Technol 2001;55:16-23.
22. Buchegger F, Haskell CM, Schreyer M, Scazziga BR, Randin S, Carrel S, Mach JP. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. J Exp Med 1983;158:413-427.
23. Sutherland RM, Buchegger F, Schreyer M, Vacca A, Mach JP. Penetration and binding of radiolabeled anticarcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. Cancer Res 1987;47:1627-1633.
24. Sutherland RM, Sordat B, Bamat J, Gabbert H, Bourrat B, Mueller-Klieser W. Oxygenation and differentiation in multicellular spheroids of human colon carcinoma. Cancer Res 1986;46:5320-5329.
25. Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984;10: 787-800.
26. Lepock JR. Cellular effects of hyperthermia: Relevance to the minimum dose for thermal damage. Int J Hyperthermia 2003;19:252-266.
27. Jordan O, Doelker E, Defabiani N, Caviezel A, Iselin C. Novel injectable urethral bulking agents for the treatment of urinary incontinence. J Mater Sci Mater Med 2004;15:519-522.
28. Bohner M. Theoretical considerations on the injectability of calcium phosphate cements. Proceedings of the 17th European Society for Biomaterials Conference, Barcelona, Spain, September 2002.
29. Bohner M, Baroud G. Injectability of calcium phosphate pastes. Biomaterials 2005;26:1553-1563.
30. Bernhardt JH, Brix G. Safety aspects of magnetic fields. In: Andra W and Nowak H, editors. Magnetism in Medicine. Weinheim: Wiley; 2007. pp 76-95.
31. Gellermann J, Wust P, Stalling D, Seebass M, Nadobny J, Beck R, Hege HC, Deuflhard P, Felix R. Clinical evaluation and verification of the hyperthermia treatment planning system HyperPlan. Int J Radiat Oncol Biol Phys 2000;47: 1145-1156.
32. Ivkov R, DeNardo SJ, Daum W, Foreman AR, Goldstein RC, Nemkov VS, DeNardo GL. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer. Clin Cancer Res 2005;11: 7093s-7103s.
33. Wust P, Gneveckow U, Johannsen M, Bohmer D, Henkel T, Kahmann F, Sehouli J, Felix R, Ricke J, Jordan A. Magnetic nanoparticles for interstitial thermotherapy - Feasibility, tolerance and achieved temperatures. Int J Hyperthermia 2006;22:673-685.
34. Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, Waldofner N, Scholz R, Jordan A, Loening SA, Wust P. Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging, and three-dimensional temperature distribution. Eur Urol 2006;52:1653-1662.
35. Johannsen M, Gneveckow U, Taymoorian K, Thiesen B, Waldofner N, Scholz R, Jung K, Jordan A, Wust P, Loening SA. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial. Int J Hyperthermia 2007;23:315-323.
36. Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, Feussner A, von Deimling A, Waldoefner N, Felix R, et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: Results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol 2007;81:53-60.
37. Hilger I, Andra W, Hergt R, Hiergeist R, Schubert H, Kaiser WA. Electromagnetic heating of breast tumors in interventional radiology: In vitro and in vivo studies in human cadavers and mice. Radiology 2001;218:570-575.
38. Hilger I, Hiergeist R, Hergt R, Winnefeld K, Schubert H, Kaiser WA. Thermal ablation of tumors using magnetic nanoparticles - An in vivo feasibility study. Invest Radiol 2002;37:580-586.
39. Lyng H, Rofstad EK. Thermal dose and secondary tumour cell death. Int J Hyperthermia 1993;9:755-761.
40. Moroz P, Jones SK, Gray BN. The effect of tumour size on ferromagnetic embolization hyperthermia in a rabbit liver tumour model. Int J Hyperthermia 2002;18:129-140. (Pubitemid 34232556)
41. Andra W, d'Ambly CG, Hergt R, Hilger I, Kaiser WA. Temperature distribution as function of time around a small spherical heat source of local magnetic hyperthermia. J Magn Magn Mater 1999;194:197-203.
42. Rabin Y. Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense? Int J Hyperthermia 2002;18:194-202.
43. Kolios MC, Worthington AE, Holdsworth DW, Sherar MD, Hunt JW. An investigation of the flow dependence of temperature gradients near large vessels during steady state and transient tissue heating. Phys Med Biol 1999;44: 1479-1497.
44. Hergt R, Andra W. Magnetic hyperthermia and thermoablation. In: Andra W and Nowak H, editors. Magnetism in Medicine. Weinheim: Wiley; 2007. pp 551-570.
45. Dewhirst MW, Sneed PK. Those in gene therapy should pay closer attention to lessons from hyperthermia. Int J Radiat Oncol Biol Phys 2003;57:597-599.
46. Hergt R, Andra W, d'Ambly CG, Hilger I, Kaiser WA, Richter U, Schmidt HG. Physical limits of hyperthermia using magnetite fine particles. IEEE Trans Magn 1998;34: 3745-3754.